{"name":"Laboratório Teuto Brasileiro S/A","slug":"laborat-rio-teuto-brasileiro-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Profenid","genericName":"Profenid","slug":"profenid","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Profenid","genericName":"Profenid","slug":"profenid","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOaHRLMFY1d2VrWGo3Nnc2YWQwb0ZxZGsxWVg3ZG1VY3UtVHh2LVI4ZHJ1ZktJRmpCTGlOVUtHdmtLVEpjOVNxZm94dm9OY3VsYlp3bThpQ1lVWkdWcHFKYUpxb3A2dld0OUh6ZkstWTBrQ09nY0dMVGtaWENpYnE5Q3FhcWlXVUdWbmg4OUJGTWdpSlA2TTZ0dUlKSmoxY04yZ1E?oc=5","date":"2017-07-05","type":"patent","source":"Fierce Pharma","summary":"Pfizer takes 30 cents and runs from its failing Brazilian generics venture - Fierce Pharma","headline":"Pfizer takes 30 cents and runs from its failing Brazilian generics venture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOdHVJS3hzS2tPOHRjNTZOeEJydndVRDBhQXBaSXMxV3I2NV96MmJISzRfSXpfQ0p1NjFNZDh5dVF5WXc3TS10RlBPdG4tUkZJYnZscGZYclhsa0xNTVFxaGFwWm9CS29ScUk2VmZhdlFwb1RTS25YMktRZUtYNzRYcWE5T2J0eXZESXI2d0RFeWs5dkY1ZUF1V2VVbHN6Y2M0YkVYSjB2UFY4aXhnVXIxdEh0Nl9xMk1TVTBDb2xn?oc=5","date":"2016-07-27","type":"pipeline","source":"Fierce Pharma","summary":"Teva, Mylan eye Pfizer’s Brazil unit - Fierce Pharma","headline":"Teva, Mylan eye Pfizer’s Brazil unit","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}